KE3166A - Stable antibiotic compositions - Google Patents

Stable antibiotic compositions

Info

Publication number
KE3166A
KE3166A KE3166A KE316681A KE3166A KE 3166 A KE3166 A KE 3166A KE 3166 A KE3166 A KE 3166A KE 316681 A KE316681 A KE 316681A KE 3166 A KE3166 A KE 3166A
Authority
KE
Kenya
Prior art keywords
antibiotic compositions
stable antibiotic
stable
compositions
antibiotic
Prior art date
Application number
KE3166A
Other languages
English (en)
Inventor
William Wellesley Armstrong
Saurabhkumar Jayavantrai Desai
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of KE3166A publication Critical patent/KE3166A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrrole Compounds (AREA)
KE3166A 1976-01-02 1981-10-15 Stable antibiotic compositions KE3166A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/646,295 US4018889A (en) 1976-01-02 1976-01-02 Oxytetracycline compositions
CA268,177A CA1075603A (en) 1976-01-02 1976-12-17 Stable solutions of doxycycline in aqueous 2-pyrrolidone
KR7700012A KR810000900B1 (ko) 1976-01-02 1977-01-06 항생물질 조성제의 안정화 방법

Publications (1)

Publication Number Publication Date
KE3166A true KE3166A (en) 1981-11-06

Family

ID=27164830

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3166A KE3166A (en) 1976-01-02 1981-10-15 Stable antibiotic compositions

Country Status (29)

Country Link
US (3) US4018889A (xx)
JP (1) JPS5290616A (xx)
KR (1) KR810000900B1 (xx)
AR (1) AR209242A1 (xx)
AT (1) AT345977B (xx)
BE (1) BE849885A (xx)
BG (1) BG36493A3 (xx)
CA (2) CA1075603A (xx)
CH (1) CH616080A5 (xx)
CS (1) CS205030B2 (xx)
DD (1) DD129997A5 (xx)
DE (1) DE2659152C2 (xx)
DK (1) DK145753C (xx)
EG (1) EG12291A (xx)
FI (1) FI56116C (xx)
FR (1) FR2336937A1 (xx)
GB (1) GB1520197A (xx)
GR (1) GR65305B (xx)
HK (1) HK30181A (xx)
IE (1) IE44767B1 (xx)
IN (1) IN145845B (xx)
KE (1) KE3166A (xx)
LU (1) LU76493A1 (xx)
NL (1) NL166620C (xx)
OA (1) OA05524A (xx)
PT (1) PT66017B (xx)
SE (1) SE435997B (xx)
SU (1) SU1309901A3 (xx)
ZA (1) ZA767689B (xx)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126680A (en) * 1977-04-27 1978-11-21 Pfizer Inc. Tetracycline antibiotic compositions
EP0009559B1 (de) * 1978-08-01 1982-08-25 Ciba-Geigy Ag Stabile flüssige Arzneimittelformulierung, ihre Herstellung und Verwendung
EP0012496B1 (en) * 1978-12-08 1983-07-20 Beecham Group Plc A process for the preparation of a solid sodium amoxycillin and aqueous solutions thereof
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
IE49934B1 (en) * 1979-07-02 1986-01-08 Pfizer Long acting sulfonamide injectable compositions
US4303643A (en) * 1979-07-05 1981-12-01 Pfizer Inc. Sulfonamide compositions
EP0022342B1 (en) * 1979-07-05 1983-06-15 Pfizer Inc. Sulfonamide solutions
CA1163197A (en) * 1980-04-10 1984-03-06 Herman Horn Injectable oxytetracycline compositions
US4399127A (en) * 1980-04-10 1983-08-16 Diamond Shamrock Corporation Injectable oxytetracycline compositions
US4386083A (en) * 1980-04-10 1983-05-31 Walter Hacke Injectable oxytetracycline compositions
US4374826A (en) * 1980-07-21 1983-02-22 Pfizer Inc. Sulfonamide compositions
NL178941C (nl) * 1982-06-15 1986-06-16 Aesculaap Bv Werkwijze voor de bereiding van een waterig oxytetracyclinepreparaat.
US4769232A (en) * 1984-03-22 1988-09-06 Pfizer Inc. Parenteral formulations of indolmycin
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
HU194493B (en) * 1985-11-27 1988-02-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing primycin-containing colloidal basic gel and compositions comprising the same
FR2608044B1 (fr) * 1986-12-10 1992-09-11 Sogeval Composition antibiotique aqueuse a usage veterinaire
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US6756365B2 (en) * 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
EP0626171A1 (de) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
ES2130069B1 (es) * 1997-04-10 2000-03-01 Basf Labiana S A Preparacion farmaceutica con liberacion retardada del producto activo.
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
HUP0202798A3 (en) 1999-09-14 2003-11-28 Trustees Of Tufts College Medf Methods of preparing substituted tetracyclines with transition metal-based reactions
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US20030153585A1 (en) * 2000-01-13 2003-08-14 Sven-Alexander Schreder Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary
AU3105801A (en) * 2000-01-24 2001-07-31 Trustees Of Tufts College Tetracycline compounds for treatment of cryptosporidium parvum related disorders
US6818634B2 (en) * 2000-03-31 2004-11-16 Paratek Pharmaceuticals, Inc. 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
EP1286954B1 (en) 2000-05-15 2004-04-14 Paratek Pharmaceuticals, Inc. 7-substituted fused ring tetracycline compounds
US20020128238A1 (en) * 2000-06-16 2002-09-12 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US20040224927A1 (en) * 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
US6624168B2 (en) 2000-07-07 2003-09-23 Trustees Of Tufts College 7,8 and 9-substituted tetracycline compounds
CZ2003332A3 (cs) 2000-07-07 2003-05-14 Trustees Of Tufts College 13-Substituované methacyklinové sloučeniny
CN102336679A (zh) 2000-07-07 2012-02-01 塔夫茨大学信托人 7-取代的四环素化合物
CA2415178C (en) 2000-07-07 2010-05-25 Trustees Of Tufts College 9-substituted minocycline compounds
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
US20050143353A1 (en) * 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
US7553828B2 (en) * 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
EP1241160A1 (en) * 2001-03-13 2002-09-18 Glaxo Group Limited Tetracycline derivatives and their use as antibiotic agents
AU2002250331A1 (en) * 2001-03-13 2002-09-24 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
EP2298732A1 (en) 2001-03-13 2011-03-23 Paratek Pharmaceuticals, Inc. 7,9-Substituted tetracycline compounds
EP1381372A2 (en) 2001-03-14 2004-01-21 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as synergistic antifungal agents
WO2002072022A2 (en) * 2001-03-14 2002-09-19 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as antifungal agents
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
WO2002085303A2 (en) 2001-04-24 2002-10-31 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
US20030181371A1 (en) * 2001-12-28 2003-09-25 Angiotech Pharmaceuticals, Inc. Compositions and methods of using collajolie
JP2005514410A (ja) 2002-01-08 2005-05-19 パラテック ファーマシューティカルズ インコーポレイテッド ４−デジメチルアミノテトラサイクリン化合物
CA2478335C (en) 2002-03-08 2011-05-10 Paratek Pharmaceuticals, Inc. Amino-methyl substituted tetracycline compounds
AU2003218243B2 (en) 2002-03-21 2010-04-01 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
US6958161B2 (en) 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
KR101089429B1 (ko) 2002-07-12 2011-12-07 파라테크 파마슈티컬스, 인크. 3, 10, 및 12ａ 치환된 테트라시클린 화합물
JP2006503898A (ja) 2002-10-24 2006-02-02 パラテック ファーマシューティカルズ， インク． マラリア治療のための置換テトラサイクリン化合物
CN1732023A (zh) * 2002-12-27 2006-02-08 血管技术国际股份公司 组合物和使用collajolie的方法
JP4738333B2 (ja) 2003-07-09 2011-08-03 パラテック ファーマシューティカルズ インコーポレイテッド ９−アミノメチルテトラサイクリン化合物のプロドラッグ
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
EA200600221A1 (ru) 2003-07-09 2006-06-30 Пэрэтек Фамэсьютикэлс, Инк. Замещённые соединения тетрациклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта
AU2004261143B2 (en) * 2003-07-25 2009-11-05 Allergan Pharmaceuticals International Limited A doxycycline metal complex in a solid dosage form
WO2005070878A1 (en) * 2004-01-15 2005-08-04 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
EP2301916A3 (en) 2004-10-25 2011-09-28 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
EP2033950A1 (en) 2004-10-25 2009-03-11 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
EP1855690B1 (en) * 2005-01-21 2016-06-01 Warner Chilcott Company, LLC A tetracycline metal complex in a solid dosage form
WO2006084265A1 (en) * 2005-02-04 2006-08-10 Paratek Pharmaceuticals, Inc. 11a, 12-DERIVATIVES OF TETRACYCLINE COMPOUNDS
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
JP2009502809A (ja) * 2005-07-21 2009-01-29 パラテック ファーマシューティカルズ インコーポレイテッド １０−置換テトラサイクリンおよびその使用方法
EP1991236A2 (en) 2006-01-24 2008-11-19 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
CA2649221A1 (en) * 2006-04-17 2007-10-25 Evgeny Tsiperman Isolation of tetracycline derivatives
EP2857386B1 (en) * 2006-04-24 2017-02-22 Teva Pharmaceutical Industries Ltd Tigecycline crystalline forms and processes for preparation thereof
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
WO2007133798A2 (en) * 2006-05-15 2007-11-22 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
WO2008045507A2 (en) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of bacillus anthracis infections
EP3812372A3 (en) 2006-12-21 2021-06-30 Paratek Pharmaceuticals, Inc. 7-heterocyclyl substituted sancycline derivatives for treating bacterial, viral and parasitic infections (e.g. malaria) or inflammatory diseases
WO2008079363A2 (en) 2006-12-21 2008-07-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
JP2010523684A (ja) * 2007-04-12 2010-07-15 パラテック ファーマシューティカルズ インコーポレイテッド テトラサイクリン化合物を用いる、脊髄筋委縮症を治療するための方法
JP2010525069A (ja) * 2007-04-27 2010-07-22 パラテック ファーマシューティカルズ インコーポレイテッド アミノアルキルテトラサイクリン化合物の合成方法および精製方法
DK2176216T3 (da) 2007-07-06 2012-07-30 Paratek Pharm Innc Fremgangsmåder til syntetisering af 9-substitueret minocyclin
KR20100126469A (ko) 2008-03-05 2010-12-01 파라테크 파마슈티컬스, 인크. 미노사이클린 화합물 및 이들의 사용 방법
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
AU2009236631A1 (en) * 2008-04-14 2009-10-22 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
TW202332671A (zh) 2008-05-23 2023-08-16 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
WO2010017310A1 (en) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
CA2737470A1 (en) * 2008-09-19 2010-03-25 Paratek Pharmaceuticals, Inc. Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment
CA2758322C (en) 2009-04-10 2019-04-02 Tufts Medical Center, Inc. Par-1 activation by metalloproteinase-1 (mmp-1)
RU2647972C2 (ru) 2010-05-12 2018-03-21 Ремпекс Фармацеутикалс, Инк. Тетрациклиновая композиция
EP2707003B1 (en) 2011-05-12 2019-05-01 Paratek Pharmaceuticals, Inc. Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the same
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
WO2015021387A2 (en) * 2013-08-09 2015-02-12 Britt George N Formulations for control and prevention of periodontal and perimplant diseases and other diseases and conditions of the mouth, and supra and sub-gingival delivery methods and systems for such formulations
CN103536530A (zh) * 2013-10-30 2014-01-29 王玉万 盐酸多西环素长效注射剂及制备方法
CA2980527A1 (en) 2015-03-23 2016-09-29 BioPharmX, Inc. Pharmaceutical tetracycline composition for dermatological use
CN104721133B (zh) * 2015-04-14 2018-05-18 四川美嘉龙生物科技有限公司 一种土霉素制剂及制备方法
US10383884B2 (en) 2016-11-01 2019-08-20 Paratek Pharmaceuticals, Inc. 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP)
WO2019016609A1 (en) 2017-07-21 2019-01-24 Allergan Pharmaceuticals International Limited TREATMENT OF NON-INFLAMMATORY LESIONS
AU2018374490B2 (en) 2017-11-28 2024-05-16 New Matterhorn, Llc Method for producing trehalose employing a trehalose phosphorylase variant
US11426351B2 (en) 2019-12-26 2022-08-30 Sunstar Inc. Process for producing a pharmaceutical composition containing micro particles

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB805026A (en) * 1956-03-02 1958-11-26 Konink Nl Gisten Spiritusfabri Process for enhancing the solubility of medicines in water
GB802111A (en) * 1956-09-25 1958-10-01 Irwin Irville Lubowe Improved non-toxic pesticidal compositions
US2990331A (en) * 1956-11-23 1961-06-27 Pfizer & Co C Stable solutions of salts of tetracyclines for parenteral administration
DE1091287B (de) * 1957-04-09 1960-10-20 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung stabiler, waessriger Loesungen von Tyrothricin und Subtilin
US2980584A (en) * 1957-10-29 1961-04-18 Pfizer & Co C Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
US2987437A (en) * 1958-03-06 1961-06-06 Gen Aniline & Film Corp Nematocidal composition
US3062717A (en) * 1958-12-11 1962-11-06 Pfizer & Co C Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation
NL6607516A (xx) * 1966-05-31 1967-12-01
US3957972A (en) * 1966-05-31 1976-05-18 Koninklijke Nederlandsche Gist-En Spiritusfabriek N.V. Stable solutions of oxytetracycline suitable for parenteral and peroral administration and process of preparation
DE1767891C3 (de) * 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3957980A (en) * 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
GB1508601A (en) * 1974-01-19 1978-04-26 Norbrook Labor Ltd Oxytetracycline solution
DK138974B (da) * 1974-02-19 1978-11-27 Ciba Geigy Ag Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US3957994A (en) * 1974-12-19 1976-05-18 Nelson Research & Development Company Topical anti-inflammatory composition and method of use
US3932653A (en) * 1974-12-19 1976-01-13 Nelson Research & Development Co. Composition and method for topical administration of griseofulvin
GB1538903A (en) 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent

Also Published As

Publication number Publication date
CA1072012A (en) 1980-02-19
HK30181A (en) 1981-07-10
CS205030B2 (en) 1981-04-30
FI56116C (fi) 1979-12-10
JPS5290616A (en) 1977-07-30
DK584676A (da) 1977-07-03
IE44767L (en) 1977-07-02
DK145753C (da) 1983-08-08
LU76493A1 (xx) 1977-07-05
FI56116B (fi) 1979-08-31
JPS565368B2 (xx) 1981-02-04
DK145753B (da) 1983-02-21
AT345977B (de) 1978-10-10
GB1520197A (en) 1978-08-02
US4086332A (en) 1978-04-25
AU2057176A (en) 1978-09-28
EG12291A (en) 1978-09-30
ATA971776A (de) 1978-02-15
US4081528A (en) 1978-03-28
BE849885A (fr) 1977-06-28
SU1309901A3 (ru) 1987-05-07
GR65305B (en) 1980-08-01
KR810000900B1 (ko) 1981-08-19
DE2659152A1 (de) 1977-07-14
BG36493A3 (en) 1984-11-15
PT66017A (en) 1977-01-01
AR209242A1 (es) 1977-03-31
US4018889A (en) 1977-04-19
PT66017B (en) 1978-06-19
NL166620B (nl) 1981-04-15
CH616080A5 (xx) 1980-03-14
ZA767689B (en) 1977-12-28
IE44767B1 (en) 1982-03-24
NL7614470A (nl) 1977-07-05
FR2336937A1 (fr) 1977-07-29
OA05524A (fr) 1981-04-30
FR2336937B1 (xx) 1980-06-27
FI763716A (xx) 1977-07-03
DD129997A5 (de) 1978-03-01
IN145845B (xx) 1979-01-06
SE7613959L (sv) 1977-07-03
CA1075603A (en) 1980-04-15
DE2659152C2 (de) 1984-04-05
NL166620C (nl) 1981-09-15
SE435997B (sv) 1984-11-05

Similar Documents

Publication Publication Date Title
KE3166A (en) Stable antibiotic compositions
JPS5285123A (en) Fluorocarbonsiloxane compositions
JPS53136514A (en) Stable antibiotics composition
AU2732277A (en) Soil-hardening composition
AU510212B2 (en) 1-diamino-oxytocin compositions
JPS52128946A (en) Compositions
AU516060B2 (en) Sterolin compositions
JPS5341437A (en) Antibiotic mouth composition
JPS5371075A (en) Compositions
ZA773013B (en) Anti-odorant compositions
GB1547106A (en) Grightening compositions
JPS5354593A (en) Solid compositions
GB1551637A (en) Hygieniccosmetic compositions
AU3168077A (en) Antibiotic formulations
AU514573B2 (en) Compositions
JPS52105293A (en) Antibiotic composition
JPS533533A (en) Antibiotic composition
GB1552517A (en) Colour-former compositions
ZA774715B (en) Novel antibiotic
JPS533532A (en) Antibiotic composition
GB1543360A (en) Nitrovin compositions
JPS5326395A (en) Novel antibiotic
JPS5283992A (en) Novel antibiotic
IL51106A0 (en) Stable antibiotic compositions
MY8100272A (en) Stable antibiotic compositions